Skip to main content
Top
Published in: Supportive Care in Cancer 12/2021

01-12-2021 | Original Article

Increasing physical activity in Cancer Survivors through a Text-messaging Exercise motivation Program (ICanSTEP)

Authors: Bridget F. Koontz, Erica Levine, Frances McSherry, Donna Niedzwiecki, Linda Sutton, Tykeytra Dale, Martin Streicher, Christel Rushing, Lynda Owen, William E. Kraus, Gary Bennett, Kathryn I. Pollak

Published in: Supportive Care in Cancer | Issue 12/2021

Login to get access

Abstract

Purpose

Cancer survivors are often sedentary. Self-monitoring may promote physical activity through self-activation. We conducted a pilot trial to evaluate whether wearable activity tracker with personalized text message feedback would increase physical activity.

Methods

We enrolled 30 patients with solid tumor cancers into a non-randomized prospective intervention trial (NCT02627079): 15 had completed treatment in the past year and 15 under active treatment. Each participant received an activity tracker and daily text messages personalized to their activity level. We assessed patient-reported outcomes and 6-min walk (6 MW) at baseline and 3 months.

Results

Twenty-six participants completed the study. There was substantial variation in baseline activity. Overall, 39% of participants increased their steps taken by at least 20%, and 23% increased their 6 MW distance by 20% or more. More participants who had completed treatment strongly agreed (73%) that the intervention increased their exercise levels than those receiving active treatment (47%). At 3 months, there was a significant improvement in median Beck Depression Inventory-II and Godin Leisure Index composite scores. At 6 months, 72% still wore their activity tracker at least 4 days per week.

Conclusion

We found that the intervention was well-accepted with a high completion rate at 3 months and continued self-use at 6 months. In this pilot study of combined activity tracker and motivational messaging, we found a signal for increased physical activity over a 3-month period. Future research is needed to study this technique for its impact on activity and other physical and psychological measures of well-being.

Implication for cancer survivors

Activity tracker with personalized motivational messaging may be useful in promoting physical activity in cancer survivors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Society AC (2019) Cancer treatment and survivorship facts & figures 2019. American Cancer Society, Atlanta Society AC (2019) Cancer treatment and survivorship facts & figures 2019. American Cancer Society, Atlanta
5.
go back to reference Capozzi LC, Boldt KR, Lau H, Shirt L, Bultz B, Culos-Reed SN (2014) A clinic-supported group exercise program for head and neck cancer survivors: managing cancer and treatment side effects to improve quality of life. Support Care Cancer. https://doi.org/10.1007/s00520-014-2436-4 Capozzi LC, Boldt KR, Lau H, Shirt L, Bultz B, Culos-Reed SN (2014) A clinic-supported group exercise program for head and neck cancer survivors: managing cancer and treatment side effects to improve quality of life. Support Care Cancer. https://​doi.​org/​10.​1007/​s00520-014-2436-4
10.
11.
go back to reference Sweegers MG, Altenburg TM, Chinapaw MJ, Kalter J, Verdonck-de Leeuw IM, Courneya KS et al (2018) Which exercise prescriptions improve quality of life and physical function in patients with cancer during and following treatment? A systematic review and meta-analysis of randomised controlled trials. Br J Sports Med 52(8):505–513. https://doi.org/10.1136/bjsports-2017-097891CrossRefPubMed Sweegers MG, Altenburg TM, Chinapaw MJ, Kalter J, Verdonck-de Leeuw IM, Courneya KS et al (2018) Which exercise prescriptions improve quality of life and physical function in patients with cancer during and following treatment? A systematic review and meta-analysis of randomised controlled trials. Br J Sports Med 52(8):505–513. https://​doi.​org/​10.​1136/​bjsports-2017-097891CrossRefPubMed
26.
go back to reference Laboratories ACoPSfCPF (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–7. Laboratories ACoPSfCPF (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–7.
31.
go back to reference Hopko DR, Bell JL, Armento ME, Robertson SM, Hunt MK, Wolf NJ et al (2008) The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol 26(1):31–51CrossRef Hopko DR, Bell JL, Armento ME, Robertson SM, Hunt MK, Wolf NJ et al (2008) The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol 26(1):31–51CrossRef
37.
go back to reference Isaacs AJ, Critchley JA, Tai SS, Buckingham K, Westley D, Harridge SD et al. (2007) Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only. Health Technol Assess; 11(10):1–165, iii-iv. Isaacs AJ, Critchley JA, Tai SS, Buckingham K, Westley D, Harridge SD et al. (2007) Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only. Health Technol Assess; 11(10):1–165, iii-iv.
Metadata
Title
Increasing physical activity in Cancer Survivors through a Text-messaging Exercise motivation Program (ICanSTEP)
Authors
Bridget F. Koontz
Erica Levine
Frances McSherry
Donna Niedzwiecki
Linda Sutton
Tykeytra Dale
Martin Streicher
Christel Rushing
Lynda Owen
William E. Kraus
Gary Bennett
Kathryn I. Pollak
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06281-y

Other articles of this Issue 12/2021

Supportive Care in Cancer 12/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine